Cargando…

Conclusions sur les avancées en transplantation()

The excellent results of Transplantation over the last decades have highlighted new challenges to be solved in the next years. (1) Modify the storage of harvested organs to improve their quality. (2) Modify strategies by taking into account the immunodeficiency in front of news infections like the o...

Descripción completa

Detalles Bibliográficos
Autor principal: Lebranchu, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: l'Académie nationale de médecine. Published by Elsevier Masson SAS. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848540/
https://www.ncbi.nlm.nih.gov/pubmed/35185154
http://dx.doi.org/10.1016/j.banm.2021.12.018
_version_ 1784652272008953856
author Lebranchu, Y.
author_facet Lebranchu, Y.
author_sort Lebranchu, Y.
collection PubMed
description The excellent results of Transplantation over the last decades have highlighted new challenges to be solved in the next years. (1) Modify the storage of harvested organs to improve their quality. (2) Modify strategies by taking into account the immunodeficiency in front of news infections like the one with Sars CoV-2. (3) Better understand the mechanisms of chronic rejection, in particular the role of innate immunity. (4) Rethink immunosuppressive strategies to prevent and to treat chronic rejections.
format Online
Article
Text
id pubmed-8848540
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher l'Académie nationale de médecine. Published by Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-88485402022-02-16 Conclusions sur les avancées en transplantation() Lebranchu, Y. Bull Acad Natl Med Article Original The excellent results of Transplantation over the last decades have highlighted new challenges to be solved in the next years. (1) Modify the storage of harvested organs to improve their quality. (2) Modify strategies by taking into account the immunodeficiency in front of news infections like the one with Sars CoV-2. (3) Better understand the mechanisms of chronic rejection, in particular the role of innate immunity. (4) Rethink immunosuppressive strategies to prevent and to treat chronic rejections. l'Académie nationale de médecine. Published by Elsevier Masson SAS. 2022-04 2022-02-16 /pmc/articles/PMC8848540/ /pubmed/35185154 http://dx.doi.org/10.1016/j.banm.2021.12.018 Text en © 2022 l'Académie nationale de médecine. Published by Elsevier Masson SAS. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article Original
Lebranchu, Y.
Conclusions sur les avancées en transplantation()
title Conclusions sur les avancées en transplantation()
title_full Conclusions sur les avancées en transplantation()
title_fullStr Conclusions sur les avancées en transplantation()
title_full_unstemmed Conclusions sur les avancées en transplantation()
title_short Conclusions sur les avancées en transplantation()
title_sort conclusions sur les avancées en transplantation()
topic Article Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848540/
https://www.ncbi.nlm.nih.gov/pubmed/35185154
http://dx.doi.org/10.1016/j.banm.2021.12.018
work_keys_str_mv AT lebranchuy conclusionssurlesavanceesentransplantation